特发性羊水过多与儿童出生后结局:外显子组测序的作用
该回顾性研究在两个产前诊断中心纳入2009年1月1日至2020年12月31年间诊断的特发性羊水过多孕妇,评估儿童长期结局。73例特发性羊水过多中25%(18/73)出现不良出生后结局,单基因病发生率为8.2%(6/73),重复羊水减量术与不良结局独立相关。
要点
- 特发性羊水过多儿童不良出生后结局发生率为25%(18/73)。
- 单基因病发生率为8.2%(6/73),随访儿童平均年龄28个月(95% CI 20-36)。
- 重复羊水减量术与不良结局独立相关。
核心结论
- 特发性羊水过多孕妇应被告知围产期死亡和出生后诊断的严重疾病风险增加25%。
研究设计与样本
- 回顾性研究,于2009年1月1日至2020年12月31日在两个产前诊断中心开展。
- 纳入标准为特发性羊水过多,定义为最大羊水池深度大于8 cm、超声未检出异常且羊水评估阴性(包括核型、染色体微阵列、生化检测(电解质和消化酶)及病毒(细小病毒B19和巨细胞病毒))。
- 共245名因孤立性羊水过多转诊的孕妇,其中73例经产前检查诊断为特发性羊水过多。
- 收集这些儿童1年结局,主要终点为不良出生后结局,定义为死产、新生儿死亡或生后第一年诊断的严重且不可治愈疾病中至少一项。
主要发现
- 不良结局发生于25%的病例(18/73),包括1例死产、2例新生儿死亡和15例出生后诊断的严重疾病。
- 单基因病发生率为8.2%(6/73)。
- 75%的儿童(55/73)儿科随访正常,其中可治愈疾病发生率为9%(5/55)。
- 随访儿童平均年龄为28个月(95% CI 20-36)。
- 重复羊水减量术与不良结局独立相关。
临床怎么用
- 特发性羊水过多孕妇应被告知围产期死亡和出生后诊断的严重疾病风险增加25%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of our study was to evaluate the long-term outcome of children born from a pregnancy complicated by idiopathic polyhydramnios. The secondary objective was to investigate factors associated with adverse outcomes. METHODS: We conducted a retrospective study in two prenatal diagnosis centers between January 1, 2009 and December 31, 2020. Inclusion criteria were pregnancies with a diagnosis of idiopathic polyhydramnios, defined by a deepest pocket greater than 8 cm, no detectable abnormality at ultrasound and a negative amniotic fluid assessment including karyotype, chromosomal microarray, biochemical assays (electrolytes and digestive enzymes), and viruses (parvovirus B19 and cytomegalovirus). One-year outcomes of these children were collected. The primary endpoint was adverse postnatal outcome, defined by at least one of the following criteria: stillbirth, neonatal death, or serious and incurable condition diagnosed in the first year of life. RESULTS: Of the 245 women referred for isolated polyhydramnios, 73 were diagnosed with idiopathic polyhydramnios after prenatal investigations. The mean age at follow-up of children was 28 months (95% CI 20-36). An adverse outcome occurred in 25% of cases (18/73), with one stillbirth, two neonatal deaths, and 15 severe conditions diagnosed postnatally, including a rate of monogenic disorders of 8.2% (6/73). Pediatric follow-up was normal for 75% of the children (55/73), including a rate of 9% (5/55) of curable conditions. Repeated amnioreduction was independently associated with an adverse outcome. CONCLUSION: Pregnant women with polyhydramnios should be informed of the increased risk of 25% of perinatal mortality and serious conditions diagnosed after birth.
引用
- Grausz N, Senat MV, Colmant C, et al. Idiopathic polyhydramnios and postnatal outcomes of children: The role of exome sequencing. Prenat Diagn. 2024. PMID: 38682787. doi:10.1002/pd.6573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。